BioLineRx Ltd. to Report First Quarter 2012 Results on May 15, 2012  
5/8/2012 10:39:04 AM

JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a biopharmaceutical development company, announced today that it will release its unaudited financial results for the three-months ended March 31, 2012 on Tuesday, May 15, 2012, before the U.S. markets open.